AzTrials
AzTrials

Brown Adipose Tissue (BAT) PhysiologyNCT02692885

Molecular, Cellular, and Genetic Characterization of Human Adipose Tissue and Its Role in Metabolism

An observational study of Brown Adipose Tissue (BAT) Physiology and Phenotyping, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Background: The body uses energy from calories for basic functions like breathing and digesting food. Over time, when a person eats more calories than they burn, they may become overweight or obese. Obesity is a major health concern. Researchers want to look at fat and muscle tissue to learn more about metabolism. Read more about this study

Who is it for?
Ages 18 to 90 yearsHealthy volunteers can take part
How many people
300 participants
Where
1 siteUnited States
Study dates
22 Mar 2016to 31 Oct 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Two cohorts will be studied in this protocol, patients undergoing clinically-indicated surgery (Cohort 1) and healthy volunteers (Cohort 2).

Who may be able to join

  • Male or female
  • Any ethnicity
  • 18 years or older
  • Subject undergoing planned, clinically-indicated surgical procedure at the NIH Clinical Center in which tissue will be accessible and available for collection by the Operating Surgeon.
  • Male or female
  • Any ethnicity
  • 18-80 year
  • For supraclavicular or dorsocervical adipose biopsy: 18F-FDG PET/CT Scan images available in the CRC PACS system (performed as part of separate protocol)

Who cannot join

  • Inability to provide consent.
  • Pregnancy
  • INCLUSION/EXCLUSION CRITERIA FOR ALL OTHER SUBJECTS (HEALTHY VOLUNTEERS AND NON-SURGICAL PATIENTS (COHORT 2):
  • History of keloids.
  • Currently taking blood thinning or anti-inflammatory medications including anti-platelet or antithrombotic medications.
  • Pregnancy
Show all 11Show fewer
  • History of pacemaker, metallic heart valves, aneurysm clip, pedicle screws, metallic foreign body in eye, or other metallic implant only if using fusion technology for the biopsy procedure.
  • Psychological conditions including (but not limited to) clinical depression, bipolar disorders, or forms of mental incapacity that would be incompatible with safe and successful participation in this study.
  • Addiction to alcohol or substances of abuse within the last 5 years; current use of drugs or alcohol (CAGE greater than or equal to 2).
  • Inability to provide consent.
  • All subjects will be fully informed of the aims, nature, and risks of the study prior to giving written informed consent.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ashley M Schmitz, C.R.N.P. contact

(920) 948-1186

ashley.schmitz@nih.gov

Aaron M Cypess, M.D. contact

(301) 435-9267

aaron.cypess@nih.gov

United States1 site, 1 recruiting
  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892

    For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR), 800-411-1222 ext. TTY dial 711, ccopr@nih.gov

    Recruiting

Other trials in United States

About this study

Official title: The Molecular, Cellular, and Genetic Characterization of Human Adipose Tissue and Its Role in Metabolism

Background:

The body uses energy from calories for basic functions like breathing and digesting food. Over time, when a person eats more calories than they burn, they may become overweight or obese. Obesity is a major health concern. Researchers want to look at fat and muscle tissue to learn more about metabolism. That is how the body uses food and other nutrients for normal function and energy. This research may help to develop new treatments for obesity and related diseases.

Read more

Objective:

To learn more about the role of fat and muscle in metabolism, particularly how fat and muscle store and use energy.

Eligibility:

Adults 18 years and older who have a planned surgery at NIH in which tissue can be collected by the surgeon.

Design:

Participants will be screened by their regular NIH doctor. Then researchers will contact them about this study.

Participants will not have to make extra visits to NIH for this study.

Researchers will collect samples during the participant s surgery. These will be fat tissue and skeletal muscle tissue. Muscle tissue will only be taken from tissue that is going to be discarded. Collecting the tissue will not add any time or any extra incisions than what is required for the surgery.

After surgery, blood will be drawn. Some participants will have this done in the pre-op or post-op room. Others will have this done during their hospital stay.

Read the detailed description

More than ever before, people are eating more calories from food than what they are burning off through exercise and other activities, and this imbalance is causing the rising rates of obesity and diabetes in the US and throughout the world. The different types of body fat are central players in this process. The white fat stores excess calories coming from food, while brown fat - also known as brown adipose tissue, or BAT - consumes the energy from food to generate heat. This important process in BAT is achieved through the action of a special protein found only in BAT, called uncoupling protein 1 (UCP1). Scientists used to believe that BAT was important only in small animals and human infants, but it was recently discovered by us and others that in response to mild cold exposure, adult human BAT (hBAT) consumes more glucose by weight than any other tissue. In addition, human BAT may also combat weight gain by becoming more active in the setting of increased food consumption. This phenomenon has already been demonstrated in mice and rats, and its presence suggests that activation of human BAT could be used as a safe treatment for obesity and metabolic disease. Finally, emerging evidence indicates that human BAT may be an endocrine organ, which means that it releases hormones into the blood and regulates other organs of the body as well, including skeletal muscle, liver, and the insulin-releasing pancreatic Beta-cell. If we are going to understand how hBAT functions in the body physiology and use its calorie-burning ability to treat illnesses of metabolism such as diabetes, we will need to approach the challenge using several different methods. One key reason is that BAT is not easy to find in the body, and the cells that make it up are different depending on where they are and what the body needs. Brown fat is composed of at least two known types of distinct cells, termed "constitutive"/brown and "inducible"/beige; and there are also white fat cells in varying proportions. Given that there is currently no known way to estimate the amount of brown fat in the body from a simple blood test, our lab group has successfully relied on collecting small amounts of fat from the site of surgery in patients who are already undergoing clinically indicated procedures. Information obtained from these fat tissues has addressed questions related to (a) how brown fat cells develop from immature stem cells; (b) what genes are active; and (c) how many calories the brown fat can burn. These earlier studies have also provided the preliminary cells necessary for establishing long-lasting human brown and white cells that can be grown indefinitely in the laboratory. Despite this progress, much remains unknown about the functional differences between brown and beige fat cells and how these could affect metabolism in humans of different age, sex, and genetic backgrounds, as well as the changes seen in the brown fat cells in different illnesses. The goal of this study is to address these and related questions.

Keywords
Phenotype, Adipose Tissue, Brown Adipose Tissue, Natural History

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02692885
Study groupRoleWhat they receive
Healthy VolunteersIndividuals known to have brown adipose tissue, identified by PET/CT following participation/scanning in other clinical studies
Surgical PatientsIndividuals undergoing planned, clinically-indicated surgeries

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Establish a comprehensive genetic and functional map of human brown and white adipose tissue.

    To understand the physiology of human BAT and its role in metabolism.

    Measured: tissue is collected the day of procedure/surgery

  2. Determine which anthropometric and genetic factors influence the growth and function of human BAT.

    To understand the physiology of human BAT and its role in metabolism.

    Measured: tissue is collected the day of procedure/surgery

  3. Identify factors within adipose tissue and plasma that (a) stimulate BAT growth and/or activity and/or (b) are released by BAT to regulate metabolism.

    To understand the physiology of human BAT and its role in metabolism.

    Measured: tissue is collected the day of procedure/surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Feb 2016 (estimated)
  2. Study start22 Mar 2016
  3. Primary completion31 Oct 2026 (estimated)
  4. Study completion31 Oct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02692885
Sponsor's protocol ID
160068
Other IDs
16-DK-0068
Status last verified
16 Sep 2026
First submitted
25 Feb 2016
Last updated
22 Sep 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures and appendices).

Questions about this trial

What is this clinical trial studying?

An observational study of Brown Adipose Tissue (BAT) Physiology and Phenotyping, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ashley M Schmitz, C.R.N.P. ((920) 948-1186, ashley.schmitz@nih.gov), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Establish a comprehensive genetic and functional map of human brown and white adipose tissue. (time frame: tissue is collected the day of procedure/surgery). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in